Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL567341 | 0.72 | CYP2C19 (0.60) | CYP2C19MEN1ALDH1A1KMT2ACYP19A1 | |
| SCHEMBL53289 | 0.72 | CYP2C19 (0.60) | CYP2C19MEN1ALDH1A1KMT2ACYP19A1 | |
| SCHEMBL17513158 | 0.72 | CYP2C19 (0.60) | CYP2C19MEN1ALDH1A1KMT2ACYP19A1 | |
| SCHEMBL30436640 | 0.72 | CYP2C19 (0.60) | CYP2C19MEN1ALDH1A1KMT2ACYP19A1 | |
| SCHEMBL31091154 | 0.72 | CYP2C19 (0.60) | CYP2C19MEN1ALDH1A1KMT2ACYP19A1 | |
| SCHEMBL2513703 | 0.72 | CYP2C19 (0.60) | CYP2C19MEN1ALDH1A1KMT2ACYP19A1 | |
| SCHEMBL30475702 | 0.72 | CYP2C19 (0.60) | CYP2C19MEN1ALDH1A1KMT2ACYP19A1 | |
| Hydrogen Peroxide SCHEMBL335838 | 0.71 | CYP2C19 (0.59) | CYP2C19MEN1ALDH1A1KMT2ACYP19A1 | |
| SCHEMBL28814740 | 0.70 | TP53 (0.40) | CYP2C19CYP19A1LMNATSHR | |
| Alcohol SCHEMBL4998384 | 0.69 | CYP2C19 (0.55) | CYP2C19ALDH1A1CYP19A1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025090057-A1 | ENCAPSULATION OF INSECTICIDES INTO BIOPOLYMER CAPSULES | UNM RAINFOREST INNOVATIONS (US) | 2025-05-01 | — | — | WO | claimed |
| CN-119280157-A | Alzeb phospholipid complex self-microemulsifying drug delivery system and preparation method and application thereof | 江苏苏南药业实业有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-118994063-A | Novel method for synthesizing eremophilne intermediate | 上海博悦生物科技有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-118047711-A | Impurity and quality detection method for eremophilus | 成都同心纵横生物医药有限公司 | 2024-05-17 | — | — | CN | claimed |
| US-20240081341-A1 | ENCAPSULATION OF INSECTICIDES INTO BIOPOLYMER CAPSULES | FUNDACAO OSWALDO CRUZ (BR) | 2024-03-14 | — | — | US | claimed |
| CN-116761630-A | Contact lens for drug delivery and ophthalmic pharmaceutical composition | 大元制药株式会社 | 2023-09-15 | — | — | CN | claimed |
| CN-115073350-B | Preparation method of eremophilone | 苏州富士莱医药股份有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-115350202-B | Application of puffball polysaccharide in preparation of medicine for preventing and treating wounds | 浙江中医药大学 | 2023-06-30 | — | — | CN | claimed |
| CN-116036077-A | Method for treating gastroesophageal reflux disease | 四川大学华西医院 | 2023-05-02 | — | — | CN | claimed |
| US-11380884-B2 | Liquid composition for producing electrode composite material, method for producing electrode, and method for producing electrochemical element | RICOH COMPANY, LTD. (JP) | 2022-07-05 | — | — | US | claimed |
| EP-2633042-A1 | MODIFIED VALENCENE SYNTHASE POLYPEPTIDES, ENCODING NUCLEIC ACID MOLECULES AND USES THEREOF | Allylix, Inc. (US) | 2013-09-04 | — | — | EP | claimed |
| US-20120246767-A1 | Modified valencene synthase polypeptides, encoding nucleic acid molecules and uses thereof | EVOLVA, INC. | 2012-09-27 | — | — | US | claimed |
| WO-2012058636-A1 | MODIFIED VALENCENE SYNTHASE POLYPEPTIDES, ENCODING NUCLEIC ACID MOLECULES AND USES THEREOF | ALLYLIX, INC. (US) | 2012-05-03 | — | — | WO | claimed |
| CN-100584838-C | Eremophilone lactones acid natural product and application thereof | UNIV ZHEJIANG | 2010-01-27 | — | — | CN | claimed |
| CN-1923827-A | Eremophilone lactones acid natural product and application thereof | UNIV ZHEJIANG (CN) | 2007-03-07 | — | — | CN | claimed |
| US-20060008491-A1 | Eremophilone and eremophilone derivatives for pest control | LEACH DAVID N | 2006-01-12 | — | — | US | claimed |
| WO-2004021784-A1 | EREMOPHILONE AND EREMOPHILONE DERIVATIVES FOR PEST CONTROL | BIOPROSPECT LIMITED (AU) | 2004-03-18 | — | — | WO | claimed |
| US-5919552-A | Coated substrates and methods | XEROX CORPORATION (US) | 1999-07-06 | — | — | US | claimed |
| US-5897961-A | USEFUL FOR INK JET PRINTING AND ELECTROSTATIC PRINTING | XEROX CORPORATION (US) | 1999-04-27 | — | — | US | claimed |
| US-5763128-A | Simulated photographic-quality images on a substrate without curl | XEROX CORPORATION (US) | 1998-06-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060008491-A1 | Eremophilone and eremophilone derivatives for pest control | CYP51A1, ERG28, MSMO1 | CYP2C19 2173/4885MEN1 76/4885ALDH1A1 3684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.